Cargando…

Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus

Influenza virus M2 protein has a highly conserved ectodomain (M2e) as a cross-protective antigenic target. We investigated the antigenic and immunogenic properties of tandem repeat M2e (5xM2e) proteins and virus-like particles (5xM2e VLP) to better understand how VLP and protein platform vaccines in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ki-Hye, Kwon, Young-Man, Lee, Young-Tae, Kim, Min-Chul, Hwang, Hye Suk, Ko, Eun-Ju, Lee, Youri, Choi, Hyo-Jick, Kang, Sang-Moo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313937/ https://www.ncbi.nlm.nih.gov/pubmed/30241300 http://dx.doi.org/10.3390/vaccines6040066

Ejemplares similares

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
por: Lee, Young-Tae, et al.
Publicado: (2018)

Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform
por: Kwon, Young-Man, et al.
Publicado: (2019)

Natural Killer and CD8 T Cells Contribute to Protection by Formalin Inactivated Respiratory Syncytial Virus Vaccination under a CD4-Deficient Condition
por: Ko, Eun-Ju, et al.
Publicado: (2020)

Systems biology from virus to humans
por: Lee, Youri, et al.
Publicado: (2015)

Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice
por: Kim, Yu-Jin, et al.
Publicado: (2017)

Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells
por: Kim, Ki-Hye, et al.
Publicado: (2015)

Respiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages
por: Lee, Young-Tae, et al.
Publicado: (2015)

Ginseng Protects Against Respiratory Syncytial Virus by Modulating Multiple Immune Cells and Inhibiting Viral Replication
por: Lee, Jong Seok, et al.
Publicado: (2015)

Antiviral activity of ginseng extract against respiratory syncytial virus infection
por: LEE, JONG SEOK, et al.
Publicado: (2014)

Immunomodulatory Activity of Red Ginseng against Influenza A Virus Infection
por: Lee, Jong Seok, et al.
Publicado: (2014)

New vaccines against influenza virus
por: Lee, Young-Tae, et al.
Publicado: (2014)

Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge
por: Park, Soojin, et al.
Publicado: (2018)

Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza Vaccination
por: Ko, Eun-Ju, et al.
Publicado: (2017)

Co-Delivery of M2e Virus-Like Particles with Influenza Split Vaccine to the Skin Using Microneedles Enhances the Efficacy of Cross Protection
por: Kim, Min-Chul, et al.
Publicado: (2019)

Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial Virus
por: Jung, Yu-Jin, et al.
Publicado: (2020)

Thermostable H1 hemagglutinin stem with M2e epitopes provides broad cross-protection against group1 and 2 influenza A viruses
por: Subbbiah, Jeeva, et al.
Publicado: (2022)

Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins
por: Lee, Yu-Na, et al.
Publicado: (2015)

A Mechanistic Study on the Destabilization of Whole Inactivated Influenza Virus Vaccine in Gastric Environment
por: Choi, Hyo-Jick, et al.
Publicado: (2013)

Recombinant vesicular stomatitis virus glycoprotein carrying a foot-and-mouth disease virus epitope as a vaccine candidate
por: LEE, Hyang-Sim, et al.
Publicado: (2020)

Roles of the Fc Receptor γ-Chain in Inducing Protective Immune Responses after Heterologous Vaccination against Respiratory Syncytial Virus Infection
por: Hwang, Hye Suk, et al.
Publicado: (2021)

Insight into Highly Conserved H1 Subtype-Specific Epitopes in Influenza Virus Hemagglutinin
por: Cho, Ki Joon, et al.
Publicado: (2014)

Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes
por: Kotomina, Tatiana, et al.
Publicado: (2020)

Virus-like nanoparticles as a theranostic platform for cancer
por: Kim, Kyeong Rok, et al.
Publicado: (2023)

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
por: Bhatnagar, Noopur, et al.
Publicado: (2023)

Rapid COVID-19 Molecular Diagnostic System Using Virus Enrichment Platform
por: Jang, Yoon Ok, et al.
Publicado: (2021)

Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses
por: Moreno, Noelia, et al.
Publicado: (2016)

BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection
por: Kim, Ki-Hye, et al.
Publicado: (2021)

Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype.
por: Kim, Young Sik, et al.
Publicado: (2002)

Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein
por: Kim, Ah-Ra, et al.
Publicado: (2018)

Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection
por: Hyun, Hakjun, et al.
Publicado: (2023)

Production of Plant-Derived Japanese Encephalitis Virus Multi-Epitope Peptide in Nicotiana benthamiana and Immunological Response in Mice
por: Jung, Jae-Wan, et al.
Publicado: (2023)

Seroepidemiology of Varicella-Zoster Virus in Korea
por: Lee, Hyunju, et al.
Publicado: (2013)

Lactobacillus plantarum DK119 as a Probiotic Confers Protection against Influenza Virus by Modulating Innate Immunity
por: Park, Min-Kyung, et al.
Publicado: (2013)

Gut microbiota as a potential key to modulating humoral immunogenicity of new platform COVID-19 vaccines
por: Seong, Hye, et al.
Publicado: (2023)

Detection rate and clinical impact of respiratory viruses in children with Kawasaki disease
por: Kim, Ja Hye, et al.
Publicado: (2012)

Rapid detection and identification of 12 respiratory viruses using a dual priming oligonucleotide system-based multiplex PCR assay
por: Kim, Suk Ran, et al.
Publicado: (2009)

Prevalence of Antibodies to Hepatitis C Virus in Patients with Various Types of Liver Diseases
por: Kim, Kang Hwan, et al.
Publicado: (1992)

Zika virus baculovirus-expressed envelope protein elicited humoral and cellular immunity in immunocompetent mice
por: Shin, Minna, et al.
Publicado: (2022)

Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma
por: Lim, Seungtaek, et al.
Publicado: (2013)

Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8(+) T cells for cancer immunotherapy
por: Jung, Keunok, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jef7e35v8l0v3rfk259b21cb11